Nanobiotix(DE:5NRA)
€27.60-0.60 (-2.13%)
DE:5NRA
Nanobiotix stock drug pipeline
€27.60
At close:-0.60 (-2.13%)
Nanobiotix (5NRA) Drug Pipeline
0 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pembrolizumab, Nivolumab, Nbtxr3, Sabr | Metastatic Nsclc, Metastatic Renal Cell Carcinoma, Squamous Cell Carcinoma Of Head And Neck, Immunotherapy, Metastatic Triple-Negative Breast Carcinoma, Radiotherapy, Microsatellite Instability-High Solid Malignant Tumour, Metastasis From Malignant Tumor Of Liver, Metastasis From Malignant Tumor Of Cervix, Metastasis From Malignant Melanoma Of Skin (Disorder), Metastasis From Malignant Tumor Of Bladder (Disorder) | Phase I | Active Not Recruiting | NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy | Apr 10, 2018 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pembrolizumab, Nivolumab, Nbtxr3, Sabr | Phase I | Metastatic Nsclc, Metastatic Renal Cell Carcinoma, Squamous Cell Carcinoma Of Head And Neck, Immunotherapy, Metastatic Triple-Negative Breast Carcinoma, Radiotherapy, Microsatellite Instability-High Solid Malignant Tumour, Metastasis From Malignant Tumor Of Liver, Metastasis From Malignant Tumor Of Cervix, Metastasis From Malignant Melanoma Of Skin (Disorder), Metastasis From Malignant Tumor Of Bladder (Disorder) | Active Not Recruiting | NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy | Apr 10, 2018 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Nanobiotix Sa ADR (DE:5NRA) have in its pipeline
Nanobiotix DE:5NRA is currently developing the following drugs: Pembrolizumab, Nivolumab, Nbtxr3, Sabr. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
